MuhammadRizwan-Ul-HaqKhawajaMDMPD
Oncology • Scottsdale, AZHematologic Oncology, Clinical Pharmacology
Associate Clinical Investigator
Dr. Khawaja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10510 N 92nd Street Suite 200
Scottsdale, AZ 85258Phone+1 480-323-1350
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Developmental Therapeutics In Oncology, 2015 - 2016
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015- Indiana University School of MedicineResidency, Internal Medicine, 2009 - 2012
Aga Khan Medical CollegeClass of 2006
Certifications & Licensure
AZ State Medical License 2022 - 2027
TX State Medical License 2017 - 2025
PA State Medical License 2017 - 2018
IN State Medical License 2013 - 2017
NM State Medical License 2016 - 2017- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
- American Board of Medical QualityCertified in Medical Quality
Publications & Presentations
PubMed
- 4 citationsHodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.Taylor Linaburg, Adam R. Davis, Noelle V. Frey, Muhammad R. Khawaja, Daniel J. Landsburg
Plos One. 2019-04-05 - 110 citationsVISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.Liru Wang, Bei Jia, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka
Oncoimmunology. 2018-07-11 - 20 citationsFirst-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patientsVivek Subbiah, Muhammad Rizwan Khawaja, David S. Hong, Behrang Amini, Jiang Yungfang
JCI Insight. 2017-04-20
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
